ACS CAN comments on Medicare Prescription Payment Plan Guidance

ACS CAN strongly advocated for inclusion in the Inflation Reduction Act of both an annual cap on total Part D out-of-pocket costs and a mechanism that would allow an enrollee the option to pay the required cost-sharing in capped monthly installments because we know from research that high out-of-pocket costs can decrease medication adherence, which results in negative health outcomes. We appreciate CMS’ release of the draft guidance, which is instructive for the first year of implementation of the Medicare Prescription Payment Plan. We strongly encourage CMS to actively monitor implementation of the Medicare Prescription Payment Plan in real time and use the lessons learned to revise the guidance accordingly in future years.